Cold-stored Platelet Early Intervention in TBI
Key facts
- Who runs it
- Jason Sperry
- Where
- Pittsburgh, United StatesSee the site
- Trial code
- Status
- Completed
- Phase
- Phase 2
- People taking part
- 100 people enrolled
- Started
- 21 Mar 2022
- Ended
- 13 May 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Cold Stored Platelets
- Standard Care
- Record updated
- 11 May 2025
Who can take part
- Age
- 18 years to 89 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Patients with traumatic brain injury, defined by presence of potential progressive intracranial injury on CT scan, at significant risk for urgent neurosurgical procedure as determined by neurosurgical evaluation, who meet at least one of the following:
- History or indication of pre-injury antiplatelet agent use
- Need for platelet transfusion per standard practice
Who cannot take part
- Currently on therapeutic anticoagulant in addition to aspirin and/or clopidogrel (e.g. warfarin, direct-acting oral anticoagulants)
- Platelet transfusion contraindications per care team (for example, recent vascular stent, embolic stroke, intracranial and/or vascular lesions)
- Age > 89 or < 18 years of age
- Wearing NO CriSP opt out bracelet
- Hypotension in Emergency Department (SBP< 90 mmHg)
- Penetrating injury
- Prisoner
- Pregnancy
- Going to operating room for non-neurosurgical intervention in first 60 minutes
- Objection to study voiced by participant or family member in Emergency Department
Where in United States
- University of PittsburghPittsburgh, United States
About the trial
What the trial wants to find out
The Cold Stored Platelet Early Intervention in Traumatic Brain Injury (CriSP-TBI) trial is a proposed 3 year, open label, single center, randomized trial designed to determine the feasibility, efficacy, and safety of urgent release cold stored platelets (CSP) in patients with TBI requiring platelet transfusion. Patients will be randomized to receive either standard care or early infusion of urgent release cold stored platelets (CSP). The proposed pilot study will enroll at the University of Pittsburgh and will enroll approximately 100 patients. The primary outcome for the pilot trial is feasibility, with principal secondary clinical outcome of 6-month Extended Glasgow Outcome Scale (GOS-E).
The 2 groups in the trial
- Cold-stored Platelet (CSP)Treatment being tested
early infusion of up to 2 units of urgent release cold stored platelets (CSP)
Treatment: Cold Stored Platelets
- Standard careExisting treatment, for comparison
standard care therapy
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Cold Stored Platelet Early Intervention in Traumatic Brain Injury Trial
- Record updated
- 11 May 2025